|
|
Article: Investigators at Southeast University, Medical Department publish new data on hepatocellular cancer.
- Article from:
- Cancer Weekly
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In this recent report, researchers in Nanjing, People's Republic of China conducted a study "To develop a sandwich enzyme-linked immunosorbent assay (ELISA) measuring hepatoma-specific datura stramonium agglutinin-tightly bounding gamma-glutamyltransferase (DSA-GGT) and evaluate its clinical application for hepatocellular carcinoma (HCC) diagnosis. Serum DSA-GGT concentrations were measured with the sandwich ELISA system in 96 patients with HCC, 240 patients with chronic liver diseases and 119 healthy subjects."
"The diagnostic performance of DSA-GGT for HCC was assessed using receiver operating characteristic (ROC) curves. The diagnostic accuracy of DSA-GGT was ...
Related newspaper, magazine, and journal articles:
|
|
Article: HCC Offers To Buy Centris.
National Underwriter Property & Casualty-Risk & Benefits Management;
January 25, 1999 ;
700+ words
... ... consider a $13.25 per share offer from HCC Insurance Holdings, Inc. Based on the ... executive officer of Houston, Texas-based HCC, told National Underwriter. He said that ... Centris was a natural target. Not only is HCC impressed with Centris' people, but the ...
|
|